Trial: 202112140

A Phase 1/1b/2 Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of AMG 193 Alone and in Combination With Docetaxel in Subjects With Advanced MTAP-null Solid Tumors

Phase

I/II (Cancer Control)

Principal Investigator

Devarakonda, Siddhartha

Disease Site

Anus; Breast; Colon; Kidney; Lip, Oral Cavity and Pharynx; Liver; Lung; Other Digestive Organ; Other Respiratory and Intrathoracic Organs; Other Urinary; Pancreas; Rectum; Small Intestine; Stomach; Urinary Bladder

Learn more about this study at: clinicaltrials.gov